Chad vs Uzbekistan: The number of people with susceptibility test result for rifampicin
Chad
7,424
in 2021
Uzbekistan
4,929
in 2021
Chad rank
26th
Uzbekistan rank
29th
The number of people with susceptibility test result for rifampicin over time
- Chad
- Uzbekistan
How they compare
Chad currently reports 7,424 against 4,929 in Uzbekistan, a difference of 2,495.
That makes Chad's figure about 1.5 times Uzbekistan's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Uzbekistan ahead.
Chad ranks 26th and Uzbekistan ranks 29th of 155 countries.
Across the 2 decades both report, Chad averaged higher in 1 and Uzbekistan in 1.
Head to head by decade
| Decade | Chad | Uzbekistan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 726.67 | 4,839 | 4,112 | Uzbekistan |
| 2020s | 5,036 | 4,438 | 598.5 | Chad |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Chad or Uzbekistan?
- Chad, at 7,424 against 4,929 in Uzbekistan as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Chad and Uzbekistan?
- 2,495, with Chad ahead.
- How many years of comparable data are there for Chad and Uzbekistan?
- 5 years are reported by both, from 2017 to 2021.
- How do Chad and Uzbekistan rank globally for the number of people with susceptibility test result for rifampicin?
- Chad ranks 26th and Uzbekistan ranks 29th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.